NHS wasting hundreds of millions of pounds says Marsh

Insurance Age staff
26 Jun 2008

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

Speaking at a conference examining healthcare acquired infections (HAIs), Robert Wendin, Head of Marsh’s Healthcare Practice for Europe, the Middle East and Africa, said that hospitals which invest in MRSA prevention can demonstrate tangible financial returns.

Mr Wendin said: “The moral duty to patients already provides a clear reason to tackle MRSA. Our analysis shows that there is now a strong financial one as well. “We calculate that HAIs can cost an average 300-bed hospital over £1.5

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected].

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

To continue reading...

Sign In

Access Insurance Age

You are currently on corporate access.